Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Total Non-Current Liabilities (2016 - 2026)

Avanos Medical's Total Non-Current Liabilities history spans 13 years, with the latest figure at $282.0 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 12.23% to $282.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $282.0 million, a 12.23% decrease, with the full-year FY2025 number at $282.0 million, down 12.23% from a year prior.
  • Total Non-Current Liabilities hit $282.0 million in Q4 2025 for Avanos Medical, up from $269.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for AVNS hit a ceiling of $487.2 million in Q3 2023 and a floor of $258.4 million in Q2 2025.
  • Historically, Total Non-Current Liabilities has averaged $387.8 million across 5 years, with a median of $416.2 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 48.48% in 2022 and later tumbled 39.24% in 2025.
  • Tracing AVNS's Total Non-Current Liabilities over 5 years: stood at $323.9 million in 2021, then skyrocketed by 46.71% to $475.2 million in 2022, then dropped by 6.12% to $446.1 million in 2023, then fell by 27.98% to $321.3 million in 2024, then fell by 12.23% to $282.0 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for AVNS at $282.0 million in Q4 2025, $269.0 million in Q3 2025, and $258.4 million in Q2 2025.